KR102179649B1 - A preparing method of diethylamino hydroxybenzoyl hexylbenzoate - Google Patents

A preparing method of diethylamino hydroxybenzoyl hexylbenzoate Download PDF

Info

Publication number
KR102179649B1
KR102179649B1 KR1020190161828A KR20190161828A KR102179649B1 KR 102179649 B1 KR102179649 B1 KR 102179649B1 KR 1020190161828 A KR1020190161828 A KR 1020190161828A KR 20190161828 A KR20190161828 A KR 20190161828A KR 102179649 B1 KR102179649 B1 KR 102179649B1
Authority
KR
South Korea
Prior art keywords
diethylaminohydroxybenzoylhexylbenzoate
present
mol
stirred
internal temperature
Prior art date
Application number
KR1020190161828A
Other languages
Korean (ko)
Other versions
KR20200002720A (en
Inventor
윤종배
백현우
최은화
Original Assignee
(주)에이에스텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)에이에스텍 filed Critical (주)에이에스텍
Publication of KR20200002720A publication Critical patent/KR20200002720A/en
Priority to PCT/KR2020/002959 priority Critical patent/WO2021071033A1/en
Priority to JP2020573548A priority patent/JP7195351B2/en
Priority to CN202080042581.9A priority patent/CN113993838A/en
Priority to DE112020004927.2T priority patent/DE112020004927T5/en
Priority to KR1020200057898A priority patent/KR102357197B1/en
Application granted granted Critical
Publication of KR102179649B1 publication Critical patent/KR102179649B1/en
Priority to TW109142958A priority patent/TW202122369A/en
Priority to JP2022154975A priority patent/JP2022188148A/en
Priority to JP2022154976A priority patent/JP2022188149A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/34Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법에 관한 것으로서, 구체적으로는 제조 공정이 용이하고 상업적 대량생산이 가능한 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법 및 이에 의하여 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자에 관한 것이다.
본 발명에 의하면 자외선 차단효과가 우수한 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자를 안정적이며 높은 수율로 얻을 수 있다.
The present invention relates to a method for preparing diethylaminohydroxybenzoylhexylbenzoate, specifically, a method for preparing diethylaminohydroxybenzoylhexylbenzoate, which is easy to manufacture and can be mass-produced commercially, and the diethylaminohydroxybenzoylhexylbenzoate prepared thereby. It relates to ethylaminohydroxybenzoylhexylbenzoate crystalline particles.
According to the present invention, diethylaminohydroxybenzoylhexylbenzoate crystalline particles having excellent UV blocking effect can be obtained in a stable and high yield.

Description

디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법 {A preparing method of diethylamino hydroxybenzoyl hexylbenzoate}Preparation method of diethylamino hydroxybenzoyl hexylbenzoate {A preparing method of diethylamino hydroxybenzoyl hexylbenzoate}

본 발명은 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법에 관한 것으로서, 구체적으로는 제조 공정이 용이하고 상업적 대량생산이 가능한 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법, 디에틸아미노하이드록시벤조일헥실벤조에이트의 결정성 입자 제조 방법 및 이에 의하여 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트에 관한 것이다.The present invention relates to a method for preparing diethylaminohydroxybenzoylhexylbenzoate, specifically, a method for producing diethylaminohydroxybenzoylhexylbenzoate, which is easy to manufacture and can be mass-produced commercially, diethylaminohydroxy It relates to a method for producing crystalline particles of benzoylhexylbenzoate and to diethylaminohydroxybenzoylhexylbenzoate prepared thereby.

햇빛에 포함된 자외선을 비롯한 모든 자외선은 발암 물질이다. 국제 암 연구기관인 IARC 는 모든 종류의 자외선을 1군 발암 물질, 즉 암 유발이 확인된 물질로 분류하고 있다. All ultraviolet rays, including ultraviolet rays contained in sunlight, are carcinogens. IARC, an international cancer research institute, classifies all types of ultraviolet rays as group 1 carcinogens, that is, substances that have been confirmed to cause cancer.

발암성 외에도 자외선은 피부와 눈, 면역체계에 손상을 입히며, 피부 노화를 일으킨다. 이론적으로 자외선을 받지 않으면 노화가 27 배 지연된다고 한다. 특히 햇빛에 많이 포함된 UV-B (320 nm ~ 280 nm)는 화상을 일으키고, 자외선 살균에 쓰이는 UV-C (280 nm ~ 100 nm)는 에너지가 커서 UV-A (400 nm ~ 320 nm)나 UV-B보다 더 해롭다. 그리고 과거에는 별로 해롭지 않다고 알려진 UV-A 또한 높은 에너지를 가지고 있어서 활성 산소를 통한 DNA 손상이 가능한 것으로 밝혀졌다. 햇빛을 받았을 때 피부가 타는 것은 유해물질로부터 피부를 보호하기 위해 일어나는 현상이라고 볼 수 있다. 피부 노화, 피부 손상 같은 건강상의 피해 외에도 주근깨나 점을 만드는 등 미용적으로도 자외선은 해를 끼친다.In addition to carcinogenicity, ultraviolet rays damage the skin, eyes and immune system and cause skin aging. Theoretically, aging is delayed 27 times without UV light. In particular, UV-B (320 nm ~ 280 nm), which is heavily contained in sunlight, causes burns, and UV-C (280 nm ~ 100 nm), which is used for ultraviolet sterilization, has high energy, so UV-A (400 nm ~ 320 nm) or It is more harmful than UV-B. In addition, UV-A, which was known to be harmless in the past, also has high energy, so it has been found that DNA damage through free radicals is possible. Burning of the skin when exposed to sunlight is a phenomenon that occurs to protect the skin from harmful substances. In addition to damage to health such as skin aging and skin damage, UV rays can also harm cosmetically, such as creating freckles and spots.

위와 같이 자외선은 각종 노화와 주름의 주범으로 여겨져 남녀노소 자외선 차단제가 권장되고 있다. 자외선 차단제는 물리적인 차단제와 화학적인 차단제로 나뉘며, 물리적인 차단제는 주로 자외선을 반사시키는 무기 화합물을 이용한 것이고 (무기 차단제), 화학적인 차단제는 자외선 에너지를 열 형태로 변화시켜 방출시키는 조성물을 이용한 것이다 (유기 차단제).As above, UV rays are considered the main cause of various aging and wrinkles, and sunscreens are recommended for all ages. Sunscreen agents are divided into physical blockers and chemical blockers, physical blockers are mainly inorganic compounds that reflect ultraviolet rays (inorganic blockers), and chemical blockers are compositions that release ultraviolet energy by converting it into heat. (Organic blocker).

무기 차단제는 티타늄디옥사이드 (이산화티타늄)과 산화아연이 주로 사용된다. 차단 효과가 우수하기는 하나 발림성이 뻑뻑한 편이고, 많이 바를 경우 피부가 허옇게 뜨는 백탁 현상이 발생하는 문제점이 있다.Inorganic blocking agents are mainly titanium dioxide (titanium dioxide) and zinc oxide. The blocking effect is excellent, but the application is stiff, and if applied a lot, there is a problem that the skin becomes flat and cloudy.

한편, 유기 차단제는 무기 차단제와 달리 그 종류가 매우 다양하나, bis-ethylhexyloxyphenol methoxyphenyl triazine(BEMT), Butyl Methoxydibenzoylmethane, Diethylamino hydroxybenzoyl hexyl benzoate(DHHB), disodium phenyl dibenzimidazole tetrasulfonate(DPDT) 등이 주로 사용된다. 이 중 하기 화학식으로 표시되는 DHHB는 UV-A를 차단하는 대표적인 유기 차단제로서 BASF사가 유럽공개공보 제1046391호를 통해 처음 개발한 제품이며 현재 Uvinul A plus라는 상품명으로 시판되고 있는 제품이다. On the other hand, organic blockers have very diverse types, unlike inorganic blockers, but bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), Butyl Methoxydibenzoylmethane, Diethylamino hydroxybenzoyl hexyl benzoate (DHHB), and disodium phenyl dibenzimidazole tetrasulfonate (DPDT) are mainly used. Among them, DHHB represented by the following formula is a representative organic blocking agent that blocks UV-A. It was first developed by BASF through European Publication No. 1046391 and is currently marketed under the brand name Uvinul A plus.

Figure 112019126469080-pat00001
Figure 112019126469080-pat00001

BASF는 국제공개공보 WO 03/097578를 통해 하기 반응식에 의하여 DHHB를 제조하는 방법을 소개하고 있다.BASF introduces a method of preparing DHHB by the following reaction scheme through International Publication WO 03/097578.

Figure 112019126469080-pat00002
Figure 112019126469080-pat00002

그러나, 이 제조방법은 에스터화 반응 (esterification) 단계에서 강산인 황산을 사용하고 고온 (105 ~ 110 ℃)에서 반응해야 하며, 반응 결과물에 붉은색의 불순물을 발생시키게 됨에 따라 탈색을 위해 많은 양의 탈색제를 사용해야 할 뿐만 아니라 여러 차례의 정제 과정을 거쳐야 하는 문제점을 가지고 있다.However, this manufacturing method uses sulfuric acid, which is a strong acid in the esterification step, and must be reacted at a high temperature (105 ~ 110 ℃), and a large amount of red color impurities are generated in the reaction product. There is a problem that not only a bleaching agent must be used, but also several purification processes must be performed.

한편, BASF는 국제공개공보 WO 2008/135360에서 DHHB를 결정화시키는 방법을 개시하였다. 그러나, 위 특허에 개시된 결정화 방법은 DHHB의 융점 (54℃) 위에서 완전히 용해 후 다시 융점 아래로 냉각시켜 고체 형태의 DHHB를 얻는 방법이며, 분쇄가 필수적이다. 이는 일반적인 양산 설비에 적용하기에 어렵기 때문에, 대량 생산에 제약이 있다. 따라서, 제조 공정이 용이하고 상업적으로 대량 생산이 가능한 DHHB 제조방법의 개발이 요구된다.On the other hand, BASF has disclosed a method of crystallizing DHHB in International Publication WO 2008/135360. However, the crystallization method disclosed in the above patent is a method of obtaining DHHB in a solid form by completely dissolving above the melting point (54°C) of DHHB and then cooling it below the melting point, and grinding is essential. Since this is difficult to apply to general mass production facilities, mass production is limited. Therefore, it is required to develop a DHHB manufacturing method that is easy to manufacture and can be mass-produced commercially.

본 발명은 강산에서 반응하여 붉은색의 불순물을 다량 발생시켜 탈색이 어려운 기존 제조방법을 개선할 수 있는 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조방법 및 이에 의하여 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트를 제공하고자 한다.The present invention is a method for preparing diethylaminohydroxybenzoylhexylbenzoate that can improve the existing manufacturing method that is difficult to decolor by generating a large amount of red impurities by reacting in a strong acid, and diethylaminohydroxybenzoylhexyl prepared thereby. To provide benzoate.

또한, 본 발명은 적은 양의 탈색제를 사용하면서도 정제 횟수를 줄일 수 있어 높은 수율과 경제적으로 생산할 수 있는 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법 및 이에 의하여 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트를 제공하고자 한다.In addition, the present invention can reduce the number of purification while using a small amount of bleaching agent, and thus a method for producing diethylaminohydroxybenzoylhexylbenzoate that can be produced economically with high yield, and diethylaminohydroxybenzoylhexyl prepared thereby To provide benzoate.

본 발명은 하기 화학식 II로 표시되는 N,N-디에틸아미노-하이드록시벤조일-벤조산에 하기 화학식 III로 표시되는 화합물을 반응시켜 하기 화학식 1로 표시되는 화합물을 제조하는 단계를 포함하는 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법을 제공한다.The present invention is diethylamino comprising the step of preparing a compound represented by the following Formula 1 by reacting a compound represented by the following Formula III with N,N-diethylamino-hydroxybenzoyl-benzoic acid represented by the following Formula II. It provides a method for producing hydroxybenzoylhexylbenzoate.

[화학식 I][Formula I]

Figure 112019126469080-pat00003
Figure 112019126469080-pat00003

[화학식 II][Formula II]

Figure 112019126469080-pat00004
Figure 112019126469080-pat00004

[화학식 III][Formula III]

Figure 112019126469080-pat00005
Figure 112019126469080-pat00005

L은 클로로, 브로모, 아이오도, 메탄설포닐, 톨루엔설포닐, 벤젠설포닐, 트리플루오로메탄설포닐, 헥실설파이트 또는 헥실알킬설포닐이다.L is chloro, bromo, iodo, methanesulfonyl, toluenesulfonyl, benzenesulfonyl, trifluoromethanesulfonyl, hexylsulfite or hexylalkylsulfonyl.

또한, 본 발명은 디에틸아미노하이드록시벤조일헥실벤조에이트의 결정성 입자 제조 방법을 제공한다.In addition, the present invention provides a method for producing crystalline particles of diethylaminohydroxybenzoylhexylbenzoate.

또한, 본 발명은 위 제조방법에 의하여 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트를 제공한다.In addition, the present invention provides diethylaminohydroxybenzoylhexylbenzoate prepared by the above preparation method.

본 발명의 제조방법에 따르면, 강산에서 반응하여 붉은색의 불순물을 다량 발생시켜 탈색이 어려운 기존 디에틸아미노하이드록시벤조일헥실벤조에이트 제조방법을 개선할 수 있다. 구체적으로 본 발명은 적은 양의 탈색제를 사용하면서도 정제 횟수를 줄일 수 있어 높은 수율로 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조할 수 있으며, 경제적으로 대량 생산할 수 있다.According to the production method of the present invention, it is possible to improve the existing method for producing diethylaminohydroxybenzoylhexylbenzoate, which is difficult to decolorize by reacting in a strong acid and generating a large amount of red impurities. Specifically, in the present invention, diethylaminohydroxybenzoylhexylbenzoate can be prepared in high yield by reducing the number of purifications while using a small amount of the bleaching agent, and economically mass-produced.

이하, 본원의 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시형태를 들어 상세히 설명한다. 본 발명의 실시형태는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 더욱 완전하게 설명하기 위해서 제공되는 것이다. 따라서, 본 발명의 실시형태는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 이하 설명하는 실시형태로 한정되는 것은 아니다.Hereinafter, embodiments of the present invention will be described in detail so that those of ordinary skill in the art to which the present invention pertains can be easily carried out. Embodiments of the present invention are provided in order to more completely explain the present invention to those of ordinary skill in the art. Accordingly, embodiments of the present invention may be modified into various other forms, and the scope of the present invention is not limited to the embodiments described below.

본 발명의 명세서 전체에서, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다.Throughout the specification of the present invention, when a part "includes" a certain component, it means that other components may be further included rather than excluding other components unless otherwise stated.

본 발명의 명세서 전체에서, 어떤 단계가 다른 단계와 "상에" 또는 "전에" 위치하고 있다고 할 때, 이는 어떤 단계가 다른 단계와 직접적 시계열적인 관계에 있는 경우뿐만 아니라, 각 단계 후의 혼합하는 단계와 같이 두 단계의 순서에 시계열적 순서가 바뀔 수 있는 간접적 시계열적 관계에 있는 경우와 동일한 권리를 포함할 수 있다.Throughout the specification of the present invention, when a step is positioned "on" or "before" another step, it is not only the case that a step is in a direct time series relationship with another step, but also the mixing step after each step and Likewise, the order of the two steps may contain the same rights as in the case of an indirect time-series relationship that can change the order of the time series.

본 발명의 명세서 전체에서 사용되는 정도의 용어 "약", "실질적으로" 등은 언급된 의미에 고유한 제조 및 물질 허용오차가 제시될 때 그 수치에서 또는 그 수치에 근접한 의미로 사용되고, 본 발명의 이해를 돕기 위해 정확하거나 절대적인 수치가 언급된 개시 내용을 비양심적인 침해자가 부당하게 이용하는 것을 방지하기 위해 사용된다. 본원 명세서 전체에서 사용되는 용어 "~ (하는) 단계" 또는 "~의 단계"는 "~를 위한 단계"를 의미하지 않는다.The terms "about", "substantially", etc. of the degree used throughout the specification of the present invention are used at or close to the numerical value when manufacturing and material tolerances specific to the stated meaning are presented, and the present invention To aid in understanding of, accurate or absolute figures are used to prevent unreasonable use of the stated disclosure by unscrupulous infringers. As used throughout the specification of the present application, the term "step (to)" or "step of" does not mean "step for".

본 발명은 하기 화학식 II로 표시되는 N,N-디에틸아미노-하이드록시벤조일-벤조산에 하기 화학식 III로 표시되는 화합물을 반응시켜 하기 화학식 1로 표시되는 화합물을 제조하는 단계를 포함하는, 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법을 제공한다:The present invention comprises the step of preparing a compound represented by the following formula 1 by reacting a compound represented by the following formula III with N,N-diethylamino-hydroxybenzoyl-benzoic acid represented by the following formula II, diethyl A method for preparing aminohydroxybenzoylhexylbenzoate is provided:

[화학식 I][Formula I]

Figure 112019126469080-pat00006
Figure 112019126469080-pat00006

[화학식 II][Formula II]

Figure 112019126469080-pat00007
Figure 112019126469080-pat00007

[화학식 III][Formula III]

Figure 112019126469080-pat00008
Figure 112019126469080-pat00008

L은 클로로, 브로모, 아이오도, 메탄설포닐, 톨루엔설포닐, 벤젠설포닐, 트리플루오로메탄설포닐, 헥실설파이트 또는 헥실알킬설포닐이다.L is chloro, bromo, iodo, methanesulfonyl, toluenesulfonyl, benzenesulfonyl, trifluoromethanesulfonyl, hexylsulfite or hexylalkylsulfonyl.

본 발명의 일 구체예에 따르면, 상기 반응은 염기 조건 하에 수행될 수 있다. According to an embodiment of the present invention, the reaction may be carried out under basic conditions.

구체적으로, 상기 염기는 탄산칼륨, 탄산나트륨, 탄산수소칼륨, 탄산수소나트륨, 수산화나트륨 및 수산화칼륨으로 이루어진 군으로부터 선택된 무기 염기일 수 있다. 다만, 이에 한정되지 않는다.Specifically, the base may be an inorganic base selected from the group consisting of potassium carbonate, sodium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, sodium hydroxide, and potassium hydroxide. However, it is not limited thereto.

또한, 상기 염기는 트리에틸아민, 다이아이소프로필에틸아민, 다이에틸아민 및 피리딘으로 이루어진 군으로부터 선택된 유기 염기일 수 있다. 다만, 이에 한정되지 않는다.In addition, the base may be an organic base selected from the group consisting of triethylamine, diisopropylethylamine, diethylamine, and pyridine. However, it is not limited thereto.

또한 본 발명의 일 구체예에 따르면, 상기 화학식 II로 표시되는 화합물은 3-디에틸아미노페놀과 무수 프탈산을 반응시켜 제조된 것일 수 있다. 다만, 이에 한정되지 않는다.In addition, according to an embodiment of the present invention, the compound represented by Formula II may be prepared by reacting 3-diethylaminophenol with phthalic anhydride. However, it is not limited thereto.

또한 본 발명의 일 구체예에 따르면, 상기 화학식 III로 표시되는 화합물은 n-헥산올을 출발물질로 하여 제조된 것일 수 있다.In addition, according to an embodiment of the present invention, the compound represented by Formula III may be prepared using n-hexanol as a starting material.

본 발명에 따르면, 본 발명은 하기 화학식 1의 화합물을 결정성 입자 제조 방법을 제공한다.According to the present invention, the present invention provides a method for preparing crystalline particles of the compound of Formula 1 below.

상기 결정화는 C1~C4 알코올을 결정화 용매로 사용하여 수행될 수 있다. 예를 들어, 상기 결정화는 메탄올, 에탄올, n-프로판올, 이소프로판올, n-부탄올, 2-부탄올, 이소부탄올 또는 t-부탄올일 수 있다.The crystallization may be performed using C1 ~ C4 alcohol as a crystallization solvent. For example, the crystallization may be methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-butanol, isobutanol or t-butanol.

구체적으로, 상기 결정화 제조 방법은 아래 단계들을 포함할 수 있다:Specifically, the crystallization manufacturing method may include the following steps:

1) 상기 화학식 I로 표시되는 디에틸아미노하이드록시벤조일헥실벤조에이트의 농축 잔사에 상기 결정화 용매를 투입하는 단계; 1) adding the crystallization solvent to the concentrated residue of diethylaminohydroxybenzoylhexylbenzoate represented by Formula I;

2) 내부 온도 30 ~ 50 ℃로 승온하여 용해시키는 단계; 2) dissolving by raising the internal temperature to 30 ~ 50 ℃;

3) 완전 용해를 확인 후, 2 ~ 4 ℃/hr의 속도로 서냉하여 결정을 천천히 석출시키며 내부 온도 15 ~ 20 ℃까지 서냉하는 단계; 3) After confirming complete dissolution, slow cooling at a rate of 2 to 4°C/hr to slowly precipitate crystals and slow cooling to an internal temperature of 15 to 20°C;

4) 2 ~ 4 ℃/hr의 속도로 서냉하여 0 ~ 5 ℃까지 냉각하여 결정성 입자를 제조하는 단계.4) Slow cooling at a rate of 2 to 4°C/hr and cooling to 0 to 5°C to produce crystalline particles.

위에서 언급한 본 발명의 제조방법에 따르면, 강산에서 반응하여 붉은색의 불순물을 다량 발생시켜 탈색이 어려운 기존 디에틸아미노하이드록시벤조일헥실벤조에이트 제조 방법을 개선할 수 있다. 구체적으로 본 발명은 적은 양의 탈색제를 사용하면서도 정제 횟수를 줄일 수 있어 높은 수율로 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조할 수 있으며, 경제적으로 대량 생산할 수 있다.According to the production method of the present invention mentioned above, it is possible to improve the existing method for producing diethylaminohydroxybenzoylhexylbenzoate, which is difficult to decolorize by reacting in a strong acid to generate a large amount of red impurities. Specifically, in the present invention, diethylaminohydroxybenzoylhexylbenzoate can be prepared in high yield by reducing the number of purifications while using a small amount of the bleaching agent, and economically mass-produced.

또한, 본 발명은 본 발명의 제조방법에 따라 제조된, 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자를 제공한다.In addition, the present invention provides diethylaminohydroxybenzoylhexylbenzoate crystalline particles prepared according to the production method of the present invention.

본 발명의 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자는 본 발명의 제조방법에 따라 수득됨으로써 결정형으로 얻어지므로 분쇄 없이 그대로 사용할 수 있는 장점을 가진다.The diethylaminohydroxybenzoylhexylbenzoate crystalline particles of the present invention are obtained in a crystalline form by being obtained according to the production method of the present invention, and thus have the advantage that they can be used as they are without grinding.

본 발명의 제조방법에 따라 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자는 평균 입자 크기가 1 μm ~ 500 μm일 수 있다. 구체적으로 평균 입자 크기는 10 μm ~ 100 μm이다.Diethylaminohydroxybenzoylhexylbenzoate crystalline particles prepared according to the preparation method of the present invention may have an average particle size of 1 μm to 500 μm. Specifically, the average particle size is 10 μm to 100 μm.

또한, 본 발명의 제조방법에 따라 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자는 벌크 밀도가 0.28 g/ml를 초과하는 것이다.Further, the crystalline particles of diethylaminohydroxybenzoylhexylbenzoate prepared according to the production method of the present invention have a bulk density exceeding 0.28 g/ml.

또한, 본 발명의 제조방법에 따라 제조된 디에틸아미노하이드록시벤조일헥실벤조에이트 결정성 입자는 그 순도가 98 중량% 이상이다. Further, the diethylaminohydroxybenzoylhexylbenzoate crystalline particles prepared according to the production method of the present invention have a purity of 98% by weight or more.

실시예Example

이하, 본 발명을 제조예 및 실시예에 의해 상세히 설명한다. 단, 하기 제조예 또는 실시예들은 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 또는 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of manufacturing examples and examples. However, the following Preparation Examples or Examples are merely illustrative of the present invention, and the contents of the present invention are not limited to the following Preparation Examples or Examples.

제조예 1. 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산의 합성Preparation Example 1. Synthesis of 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid

3-디에틸아미노페놀 (1.0 kg, 7.87 mol), 무수 프탈산 (1.17 kg, 7.87 mol)을 3-neck 플라스크에 넣은 뒤 톨루엔 (5.0 L)과 함께 교반하였다. 반응기 내부 온도를 110 ~ 115 ℃까지 승온하고 2 시간 동안 교반한 후, 0 ~ 10 ℃로 냉각하여 석출된 고체를 여과하여 표제 화합물 (1.7 kg, 89.9 %)를 얻었다.3-diethylaminophenol (1.0 kg, 7.87 mol) and phthalic anhydride (1.17 kg, 7.87 mol) were placed in a 3-neck flask and stirred with toluene (5.0 L). The internal temperature of the reactor was raised to 110 to 115 °C, stirred for 2 hours, cooled to 0 to 10 °C, and the precipitated solid was filtered to obtain the title compound (1.7 kg, 89.9%).

1H NMR (CDCl3): 12.52 (s, 1H), 7.91 (dd, 1H), 7.62 (m, 2H), 7.33 (dd, 1H), 6.74 (d, 1H), 6.13 (dd, 1H), 6.20 (d, 1H), 1.16 (m, 6H) 1 H NMR (CDCl 3 ): 12.52 (s, 1H), 7.91 (dd, 1H), 7.62 (m, 2H), 7.33 (dd, 1H), 6.74 (d, 1H), 6.13 (dd, 1H), 6.20 (d, 1H), 1.16 (m, 6H)

제조예 2-1. 1-클로로헥산의 합성Preparation Example 2-1. Synthesis of 1-chlorohexane

1-헥산올 (1.2 kg, 11.70 mol), DMF(8.5 g, 0.12 mol)를 교반하며, 내부 온도 30 ℃ 이하를 유지하면서 SOCl2 (2.1 kg, 17.6 mol)를 적가하였다. 적가 완료 후 내부 온도를 80 ~ 90 ℃로 승온하여 5 시간 동안 교반하였다. 반응 종결 확인 후, 냉각하여 정제수 5 L를 투입하고 층분리하여 표제 화합물 (1.3 kg, 94.2 %)을 얻었다.1-hexanol (1.2 kg, 11.70 mol) and DMF (8.5 g, 0.12 mol) were stirred, and SOCl 2 (2.1 kg, 17.6 mol) was added dropwise while maintaining an internal temperature of 30° C. or less. After the dropwise addition was completed, the internal temperature was raised to 80 ~ 90 ℃ and stirred for 5 hours. After confirmation of completion of the reaction, the mixture was cooled, 5 L of purified water was added, and the layers were separated to obtain the title compound (1.3 kg, 94.2%).

1H NMR (CDCl3): 3.49 (t, 2H), 1.72 (m, 2H), 1.28 (m, 2H), 1.27 (m, 4H), 0.88 (m, 3H). 1 H NMR (CDCl 3 ): 3.49 (t, 2H), 1.72 (m, 2H), 1.28 (m, 2H), 1.27 (m, 4H), 0.88 (m, 3H).

제조예 2-2. 1-브로모헥산의 합성Preparation Example 2-2. Synthesis of 1-bromohexane

1-헥산올 (1.2 kg, 11.70 mol), THF (6.0 L)를 교반하며, 내부 온도 10 ℃ 이하를 유지하면서 PBr3(3.2 kg, 17.6 mol)를 적가하였다. 적가 완료 후 내부 온도를 10 ℃ 이하로 유지하며 3 시간 동안 교반하였다. 반응 종결 확인 후, 정제수 5 L를 투입하고 층분리하여 표제 화합물 (1.8 kg, 91.4 %)을 얻었다.1-hexanol (1.2 kg, 11.70 mol) and THF (6.0 L) were stirred, and PBr 3 (3.2 kg, 17.6 mol) was added dropwise while maintaining an internal temperature of 10° C. or less. After the dropwise addition was completed, the internal temperature was maintained at 10° C. or less and stirred for 3 hours. After confirming the completion of the reaction, 5 L of purified water was added and the layers were separated to obtain the title compound (1.8 kg, 91.4%).

1H NMR (CDCl3): 3.40 (t, 2H), 1.85 (m, 2H), 1.43 (m, 2H), 1.31 (m, 4H), 0.90 (m, 3H). 1 H NMR (CDCl 3 ): 3.40 (t, 2H), 1.85 (m, 2H), 1.43 (m, 2H), 1.31 (m, 4H), 0.90 (m, 3H).

제조예 2-3. 헥실 메탄설포네이트의 합성Preparation Example 2-3. Synthesis of hexyl methanesulfonate

1-헥산올 (1.2 kg, 11.70 mol), 트리에틸아민 (2.4 kg, 23.40 mol), 염화메틸렌 (12.0 L)를 교반하며, 내부온도 10 ℃ 이하를 유지하면서 MsCl (1.6 kg, 14.0 mol)를 적가하였다. 적가 완료 후 내부 온도를 10 ℃ 이하로 유지하며 3 시간 동안 교반하였다. 정제수 5 L를 투입하여 층분리 후, 분리된 유기층을 감압 농축하여 표제 화합물 (1.9 kg, 88.1 %)을 얻었다.1-hexanol (1.2 kg, 11.70 mol), triethylamine (2.4 kg, 23.40 mol), and methylene chloride (12.0 L) were stirred, and MsCl (1.6 kg, 14.0 mol) was added while maintaining an internal temperature of 10 ℃ or less. Added dropwise. After the dropwise addition was completed, the internal temperature was maintained at 10° C. or less and stirred for 3 hours. After layer separation by adding 5 L of purified water, the separated organic layer was concentrated under reduced pressure to obtain the title compound (1.9 kg, 88.1%).

1H NMR (CDCl3): 4.23 (t, 2H), 3.00 (s, 3H), 1.75 (m, 2H), 1.40 (m, 3H), 1.32 (m, 3H), 0.90 (m, 3H). 1 H NMR (CDCl 3 ): 4.23 (t, 2H), 3.00 (s, 3H), 1.75 (m, 2H), 1.40 (m, 3H), 1.32 (m, 3H), 0.90 (m, 3H).

제조예 2-4. 헥실 4-메틸벤젠설포네이트의 합성Preparation Example 2-4. Synthesis of hexyl 4-methylbenzenesulfonate

1-헥산올 (1.2 kg, 11.70 mol), TsCl (2.7 kg, 14.0 mol), 염화메틸렌 (12.0 L)를 교반하며, 내부 온도 10 ℃ 이하를 유지하면서 트리에틸아민 (2.4 kg, 23.40 mol)를 적가하였다. 적가 완료 후 내부 온도를 10 ℃ 이하로 유지하며 6 시간 동안 교반하였다. 정제수 5 L를 투입하여 층분리 후 분리된 유기층을 감압 농축하여 표제 화합물 (2.8 kg, 93.2 %)을 얻었다.1-hexanol (1.2 kg, 11.70 mol), TsCl (2.7 kg, 14.0 mol), and methylene chloride (12.0 L) were stirred, and triethylamine (2.4 kg, 23.40 mol) was added while maintaining an internal temperature of 10 °C or less. Added dropwise. After the dropwise addition was completed, the internal temperature was maintained at 10° C. or less and stirred for 6 hours. After layer separation by adding 5 L of purified water, the separated organic layer was concentrated under reduced pressure to obtain the title compound (2.8 kg, 93.2%).

1H NMR (CDCl3): 7.78 (m, 2H), 7.34 (m, 2H), 4.02 (m, 2H), 2.45 (s, 3H), 1.65 (m, 2H), 1.47-1.04 (m, 6H), 0.85 (m, 3H). 1 H NMR (CDCl 3 ): 7.78 (m, 2H), 7.34 (m, 2H), 4.02 (m, 2H), 2.45 (s, 3H), 1.65 (m, 2H), 1.47-1.04 (m, 6H) ), 0.85 (m, 3H).

제조예 2-5. 디헥실설파이트의 합성Preparation Example 2-5. Synthesis of dihexylsulfite

1-헥산올 (1.2 kg, 11.70 mol), DMF (8.5 g, 0.12 mol)를 교반하며, 내부 온도 30 ℃ 이하를 유지하면서 SOCl2 (0.7 kg, 5.9 mol)를 적가하였다. 적가 완료 후 내부 온도를 30 ~ 40 ℃로 승온하여 8 시간 동안 교반하였다. 반응 종결 확인 후, 냉각하여 정제수 5 L를 투입하고 층분리하여 표제 화합물 (1.3 kg, 90.0 %)을 얻었다.1-hexanol (1.2 kg, 11.70 mol) and DMF (8.5 g, 0.12 mol) were stirred, and SOCl 2 (0.7 kg, 5.9 mol) was added dropwise while maintaining an internal temperature of 30° C. or less. After the dropwise addition was completed, the internal temperature was raised to 30 ~ 40 ℃ and stirred for 8 hours. After confirming the completion of the reaction, the mixture was cooled, 5 L of purified water was added, and the layers were separated to obtain the title compound (1.3 kg, 90.0%).

1H NMR (CDCl3): 3.95 (m, 4H), 1.63 (m, 4H), 1.27 (m, 6H), 0.86 (m, 12H). 1 H NMR (CDCl 3 ): 3.95 (m, 4H), 1.63 (m, 4H), 1.27 (m, 6H), 0.86 (m, 12H).

제조예 2-6. 디헥실설페이트의 합성Preparation Example 2-6. Synthesis of dihexyl sulfate

1-헥산올 (1.2 kg, 11.70 mol), DMF (8.5 g, 0.12 mol)를 교반하며, 내부 온도 30 ℃ 이하를 유지하면서 SO2Cl2 (0.8 kg, 5.9 mol)를 적가하였다. 적가 완료 후 내부 온도를 30 ~ 40 ℃로 승온하여 8 시간 동안 교반하였다. 반응 종결 확인 후, 냉각하여 정제수 5 L를 투입하고 층분리하여 표제 화합물 (1.4 kg, 87.0 %)을 얻었다.1-hexanol (1.2 kg, 11.70 mol) and DMF (8.5 g, 0.12 mol) were stirred, and SO 2 Cl 2 (0.8 kg, 5.9 mol) was added dropwise while maintaining an internal temperature of 30° C. or less. After the dropwise addition was completed, the internal temperature was raised to 30 ~ 40 ℃ and stirred for 8 hours. After confirmation of completion of the reaction, the mixture was cooled, 5 L of purified water was added, and the layers were separated to obtain the title compound (1.4 kg, 87.0%).

1H NMR (CDCl3): 4.00 (m, 4H), 1.69 (m, 4H), 1.30 (m, 6H), 0.90 (m, 12H). 1 H NMR (CDCl 3 ): 4.00 (m, 4H), 1.69 (m, 4H), 1.30 (m, 6H), 0.90 (m, 12H).

실시예 1 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 1: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

단계 1 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 제조Step 1: Preparation of diethylaminohydroxybenzoylhexylbenzoate

제조예 1에서 합성한 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 (1.1 kg, 3.51 mol), 제조예 2-1에서 합성한 1-클로로헥산 (0.5 kg, 4.22 mol), K2CO3 (0.9 kg, 7.02 mol)를 DMF 1.65 L와 교반하였다. 내부 온도를 100 ~ 110 ℃로 승온하여 4 시간 동안 교반 후, 냉각하고 에틸아세테이트 3.5 L, 정제수 3.5 L를 사용하여 추출하였다. 분리된 최종 유기층은 내부 온도 30 ~ 50 ℃에서 5 % charcoal을 사용하여 1 시간 동안 탈색 처리 후, 감압 농축하였다. 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid synthesized in Preparation Example 1 (1.1 kg, 3.51 mol), 1-chlorohexane synthesized in Preparation Example 2-1 (0.5 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) was stirred with 1.65 L of DMF. The internal temperature was raised to 100 ~ 110 °C, stirred for 4 hours, cooled, and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. The separated final organic layer was decolorized for 1 hour using 5% charcoal at an internal temperature of 30 to 50° C., and then concentrated under reduced pressure.

단계 2Step 2

단계 1에서 얻어진 농축 잔사에 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 대비 4 v/w의 메탄올 투입 후, 내부 온도 30 ~ 50 ℃로 승온하여 맑게 용해시켰다. 완전 용해를 확인 후, 3 ℃/hr의 속도로 서냉하여 결정을 천천히 석출시키며 내부 온도 15 ~ 20 ℃까지 서냉하였다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후, 다시 3 ℃/hr의 속도로 서냉하여 0 ~ 5 ℃까지 냉각한다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후 여과하여 결정성 입자 상태의 표제 화합물 (1.2 kg, 86.0 %)을 얻었다.To the concentrated residue obtained in step 1, 4 v/w of methanol compared to 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid was added, and the internal temperature was raised to 30 to 50° C. to clear dissolution. After confirming complete dissolution, slow cooling was performed at a rate of 3°C/hr to slowly precipitate crystals, followed by slow cooling to an internal temperature of 15 to 20°C. When the target temperature is reached, the temperature is maintained and stirred for 1 hour, then slowly cooled at a rate of 3°C/hr and cooled to 0 ~ 5°C. When the target temperature was reached, the temperature was maintained, stirred for 1 hour, and filtered to obtain the title compound (1.2 kg, 86.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 80.3 μm;Average particle size: 80.3 μm;

벌크 밀도: 0.34 g/ml;Bulk density: 0.34 g/ml;

순도 99.4 %.99.4% purity.

실시예 2 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 2: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

실시예 1의 단계 1에서 얻어진 농축 잔사에 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 대비 4 v/w의 에탄올 투입 후, 내부 온도 30 ~ 50 ℃로 승온하여 맑게 용해시켰다. 완전 용해를 확인 후, 3 ℃/hr의 속도로 서냉하여 결정을 천천히 석출시키며 내부 온도 15 ~ 20 ℃까지 서냉하였다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후, 다시 3 ℃/hr의 속도로 서냉하여 0 ~ 5 ℃까지 냉각한다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후 여과하여 결정성 입자 상태의 표제 화합물 (1.1 kg, 80.0 %)을 얻었다.After adding 4 v/w of ethanol to the concentrated residue obtained in step 1 of Example 1 compared to 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid, the internal temperature was raised to 30 to 50°C. Clearly dissolved. After confirming complete dissolution, slow cooling was performed at a rate of 3°C/hr to slowly precipitate crystals, followed by slow cooling to an internal temperature of 15 to 20°C. When the target temperature is reached, the temperature is maintained and stirred for 1 hour, then slowly cooled at a rate of 3°C/hr and cooled to 0 ~ 5°C. When the target temperature was reached, the temperature was maintained, stirred for 1 hour, and filtered to obtain the title compound (1.1 kg, 80.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 73.7 μm;Average particle size: 73.7 μm;

벌크 밀도: 0.32 g/mlBulk density: 0.32 g/ml

순도 99.6 %.99.6% purity.

실시예 3 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 3: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

실시예 1의 단계 1에서 얻어진 농축 잔사에 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 대비 4 v/w의 이소프로판올 투입 후, 내부 온도 30 ~ 50 ℃로 승온하여 맑게 용해시켰다. 완전 용해를 확인 후, 3 ℃/hr의 속도로 서냉하여 결정을 천천히 석출시키며 내부 온도 15 ~ 20 ℃까지 서냉하였다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후, 다시 3 ℃/hr의 속도로 서냉하여 0 ~ 5 ℃까지 냉각한다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후 여과하여 결정성 입자 상태의 표제 화합물 (1.10 kg, 80.0 %)을 얻었다.After adding 4 v/w of isopropanol compared to 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid to the concentrated residue obtained in step 1 of Example 1, the internal temperature was raised to 30 to 50°C. Clearly dissolved. After confirming complete dissolution, slow cooling was performed at a rate of 3°C/hr to slowly precipitate crystals, followed by slow cooling to an internal temperature of 15 to 20°C. When the target temperature is reached, the temperature is maintained and stirred for 1 hour, then slowly cooled at a rate of 3°C/hr and cooled to 0 ~ 5°C. When the target temperature was reached, the temperature was maintained, stirred for 1 hour, and filtered to obtain the title compound (1.10 kg, 80.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 91.2 μmAverage particle size: 91.2 μm

벌크 밀도: 0.38 g/ml;Bulk density: 0.38 g/ml;

순도 99.2 %.99.2% purity.

실시예 4 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 4: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

실시예 1의 단계 1에서 얻어진 농축 잔사에 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 대비 4 v/w의 2-부탄올 투입 후, 내부 온도 30 ~ 50 ℃로 승온하여 맑게 용해시켰다. 완전 용해를 확인 후, 3 ℃/hr의 속도로 서냉하여 결정을 천천히 석출시키며 내부 온도 15 ~ 20 ℃까지 서냉하였다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후, 다시 3 ℃/hr의 속도로 서냉하여 0 ~ 5 ℃까지 냉각한다. 목표 온도에 도달하면 해당 온도를 유지하며 1 시간 동안 교반 후 여과하여 결정성 입자 상태의 표제 화합물 (1.00 kg, 75.0 %)을 얻었다.After adding 4 v/w of 2-butanol compared to 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid to the concentrated residue obtained in step 1 of Example 1, the internal temperature was 30 to 50°C. The temperature was raised to clear dissolution. After confirming complete dissolution, slow cooling was performed at a rate of 3°C/hr to slowly precipitate crystals, followed by slow cooling to an internal temperature of 15 to 20°C. When the target temperature is reached, the temperature is maintained and stirred for 1 hour, then slowly cooled at a rate of 3°C/hr and cooled to 0 ~ 5°C. When the target temperature was reached, the temperature was maintained, stirred for 1 hour, and filtered to obtain the title compound (1.00 kg, 75.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 12.0 μm;Average particle size: 12.0 μm;

벌크 밀도: 0.28 g/ml;Bulk density: 0.28 g/ml;

순도 99.5 %.99.5% purity.

실시예 5 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 5: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

제조예 1에서 합성한 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산(1.1 kg,3.51 mol), 제조예 2-2에서 합성한 1-브로모헥산 (0.7 kg, 4.22 mol), K2CO3 (0.9 kg, 7.02 mol)를 DMF 1.65 L와 교반하였다. 내부 온도를 100 ~ 110 ℃ 로 승온하여 4 시간 동안 교반 후, 냉각하고 에틸아세테이트 3.5 L, 정제수 3.5 L를 사용하여 추출하였다. 분리된 최종 유기층은 내부 온도 30 ~ 50 ℃에서 5 % charcoal을 사용하여 1 시간 동안 탈색 처리 후, 감압 농축하였다. 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid (1.1 kg, 3.51 mol) synthesized in Preparation Example 1, 1-bromohexane (0.7 kg) synthesized in Preparation Example 2-2 , 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) was stirred with 1.65 L of DMF. The internal temperature was raised to 100 ~ 110 °C, stirred for 4 hours, cooled, and extracted using 3.5 L of ethyl acetate and 3.5 L of purified water. The separated final organic layer was decolorized for 1 hour using 5% charcoal at an internal temperature of 30 to 50°C, and then concentrated under reduced pressure.

농축 잔사는 실시예 3의 결정화 방법으로 결정화시켜 결정성 입자 상태의 표제 화합물 (0.90 kg, 65.0 %)를 얻었다.The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the title compound (0.90 kg, 65.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 69.4 μm;Average particle size: 69.4 μm;

벌크 밀도: 0.32 g/ml;Bulk density: 0.32 g/ml;

순도 99.4 %.99.4% purity.

실시예 6 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 6: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

제조예 1에서 합성한 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산(1.1 kg, 3.51 mol), 제조예 2-3에서 합성한 헥실 메탄설포네이트 (0.8 kg, 4.22 mol), K2CO3 (0.9 kg, 7.02 mol)를 DMF 1.65 L와 교반하였다. 내부 온도를 100 ~ 110 ℃로 승온하여 4 시간 동안 교반 후, 냉각하여 에틸아세테이트 3.5 L, 정제수 3.5 L를 사용하여 추출하였다. 분리된 최종 유기층은 내부 온도 30 ~ 50 ℃에서 5 % charcoal을 사용하여 1 시간 동안 탈색 처리 후, 감압 농축하였다. 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid (1.1 kg, 3.51 mol) synthesized in Preparation Example 1, hexyl methanesulfonate synthesized in Preparation Example 2-3 (0.8 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) was stirred with 1.65 L of DMF. The internal temperature was raised to 100 ~ 110 °C, stirred for 4 hours, cooled, and extracted using 3.5 L of ethyl acetate and 3.5 L of purified water. The separated final organic layer was decolorized for 1 hour using 5% charcoal at an internal temperature of 30 to 50° C., and then concentrated under reduced pressure.

농축 잔사는 실시예 3의 결정화 방법으로 결정화시켜 결정성 입자 상태의 표제 화합물 (0.73 kg, 52.4 %)을 얻었다.The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the title compound (0.73 kg, 52.4%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 25.8 μm;Average particle size: 25.8 μm;

벌크 밀도: 0.30 g/ml;Bulk density: 0.30 g/ml;

순도 99.8 %.99.8% purity.

실시예 7 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 7: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

제조예 1에서 합성한 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산(1.1 kg, 3.51 mol), 제조예 2-4에서 합성한 헥실 4-메틸벤젠설포네이트 (1.1 kg, 4.22 mol), K2CO3 (0.9 kg, 7.02 mol)를 DMF 1.65 L와 교반하였다. 내부 온도를 100 ~ 110 ℃로 승온하여 4 시간 동안 교반 후, 냉각하여 에틸아세테이트 3.5 L, 정제수 3.5 L를 사용하여 추출하였다. 분리된 최종 유기층은 내부 온도 30 ~ 50 ℃에서 5 % charcoal을 사용하여 1 시간 동안 탈색 처리 후 감압 농축하였다. 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid (1.1 kg, 3.51 mol) synthesized in Preparation Example 1, hexyl 4-methylbenzenesulfonate synthesized in Preparation Example 2-4 ( 1.1 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) was stirred with 1.65 L of DMF. The internal temperature was raised to 100 ~ 110 °C, stirred for 4 hours, cooled, and extracted using 3.5 L of ethyl acetate and 3.5 L of purified water. The separated final organic layer was decolorized for 1 hour using 5% charcoal at an internal temperature of 30 to 50°C, and then concentrated under reduced pressure.

농축 잔사는 실시예 3의 결정화 방법으로 결정화시켜 결정성 입자 상태의 표제 화합물 (0.66 kg, 47.6 %)을 얻었다.The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the title compound (0.66 kg, 47.6%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 81.3 μm;Average particle size: 81.3 μm;

벌크 밀도: 0.37 g/ml;Bulk density: 0.37 g/ml;

순도 99.5 %.99.5% purity.

실시예 8 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 8: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

제조예 1에서 합성한 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 (1.1 kg, 3.51 mol), 제조예 2-5에서 합성한 디헥실설파이트 (1.1 kg, 4.22 mol), K2CO3 (0.9 kg, 7.02 mol)를 DMF 1.65 L와 교반하였다. 내부 온도를 100 ~ 110 ℃로 승온하여 4 시간 동안 교반 후, 냉각하여 에틸아세테이트 3.5 L, 정제수 3.5 L를 사용하여 추출하였다. 분리된 최종 유기층은 내부 온도 30 ~ 50 ℃에서 5 % charcoal을 사용하여 1 시간 동안 탈색 처리 후 감압 농축하였다. 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid (1.1 kg, 3.51 mol) synthesized in Preparation Example 1, dihexylsulfite synthesized in Preparation Example 2-5 (1.1 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) was stirred with 1.65 L of DMF. The internal temperature was raised to 100 ~ 110 °C, stirred for 4 hours, cooled, and extracted using 3.5 L of ethyl acetate and 3.5 L of purified water. The separated final organic layer was decolorized for 1 hour using 5% charcoal at an internal temperature of 30 to 50°C, and then concentrated under reduced pressure.

농축 잔사는 실시예 3의 결정화 방법으로 결정화시켜 결정성 입자 상태의 표제 화합물 (1.12 kg, 80.0 %)을 얻었다.The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the title compound (1.12 kg, 80.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 45.2 μm;Average particle size: 45.2 μm;

벌크 밀도: 0.32 g/ml;Bulk density: 0.32 g/ml;

순도 99.1 %.99.1% purity.

실시예 9 : 디에틸아미노하이드록시벤조일헥실벤조에이트의 합성Example 9: Synthesis of diethylaminohydroxybenzoylhexylbenzoate

제조예 1에서 합성한 2-(4-N,N-디에틸아미노-2-하이드록시벤조일)벤조산 (1.1 kg, 3.51 mol), 제조예 2-6에서 합성한 디헥실설페이트 (1.2 kg, 4.22 mol), K2CO3 (0.9 kg, 7.02 mol)를 DMF 1.65 L와 교반하였다. 내부 온도를 100 ~ 110 ℃로 승온하여 4 시간 동안 교반 후, 냉각하여 에틸아세테이트 3.5 L, 정제수 3.5 L를 사용하여 추출하였다. 분리된 최종 유기층은 내부 온도 30 ~ 50 ℃에서 5 % charcoal을 사용하여 1 시간 동안 탈색 처리 후 감압 농축하였다. 2-(4-N,N-diethylamino-2-hydroxybenzoyl)benzoic acid synthesized in Preparation Example 1 (1.1 kg, 3.51 mol), dihexyl sulfate synthesized in Preparation Example 2-6 (1.2 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) was stirred with 1.65 L of DMF. The internal temperature was raised to 100 ~ 110 °C, stirred for 4 hours, cooled, and extracted using 3.5 L of ethyl acetate and 3.5 L of purified water. The separated final organic layer was decolorized for 1 hour using 5% charcoal at an internal temperature of 30 to 50°C, and then concentrated under reduced pressure.

농축 잔사는 실시예 3의 결정화 방법으로 결정화시켜 결정성 입자 상태의 표제 화합물 (1.09 kg, 78.0 %)을 얻었다.The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the title compound (1.09 kg, 78.0%) in the form of crystalline particles.

1H NMR (CDCl3): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H); 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H);

평균 입자 크기: 82.0 μm;Average particle size: 82.0 μm;

벌크 밀도: 0.39 g/ml;Bulk density: 0.39 g/ml;

순도 99.4 %.99.4% purity.

실시예에서 확인된 바와 같이, 본 발명의 제조방법에 따라 높은 수율로 디에틸아미노하이드록시벤조일헥실벤조에이트를 얻을 수 있으며, 탈색 및 정제 공정을 간소화할 수 있으므로 경제적으로 대량 생산이 가능하다.As confirmed in the examples, diethylaminohydroxybenzoylhexylbenzoate can be obtained in high yield according to the production method of the present invention, and since the decolorization and purification process can be simplified, mass production is economically possible.

전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술 분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성요소들도 결합된 형태로 실시될 수 있다.The above description of the present invention is for illustrative purposes only, and those of ordinary skill in the technical field to which the present invention pertains will be able to understand that it is possible to easily transform it into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not limiting. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as being distributed may also be implemented in a combined form.

본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위, 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다. The scope of the present invention is indicated by the claims to be described later rather than the detailed description, and it is interpreted that the meaning and scope of the claims, and all changes or modified forms derived from the concept of equivalents thereof are included in the scope of the present invention. Should be.

Claims (8)

하기 화학식 II로 표시되는 N,N-디에틸아미노-하이드록시벤조일-벤조산에 하기 화학식 III로 표시되는 화합물을 반응시켜 하기 화학식 1로 표시되는 화합물을 제조하는 단계를 포함하는,
디에틸아미노하이드록시벤조일헥실벤조에이트의 제조 방법:
[화학식 I]
Figure 112019126469080-pat00009

[화학식 II]
Figure 112019126469080-pat00010

[화학식 III]
Figure 112019126469080-pat00011

L은 클로로, 브로로, 아이오도, 메탄설포닐, 톨루엔설포닐, 벤젠설포닐, 트리플루오로메탄설포닐, 헥실설파이트 또는 헥실알킬설포닐이다.
Comprising the step of preparing a compound represented by the following formula 1 by reacting a compound represented by the following formula III with N,N-diethylamino-hydroxybenzoyl-benzoic acid represented by the following formula II,
Method for preparing diethylaminohydroxybenzoylhexylbenzoate:
[Formula I]
Figure 112019126469080-pat00009

[Formula II]
Figure 112019126469080-pat00010

[Formula III]
Figure 112019126469080-pat00011

L is chloro, broro, iodo, methanesulfonyl, toluenesulfonyl, benzenesulfonyl, trifluoromethanesulfonyl, hexylsulfite or hexylalkylsulfonyl.
제 1 항에 있어서,
상기 반응은 염기 조건 하에 수행되는 것인, 제조 방법.
The method of claim 1,
The reaction is to be carried out under basic conditions.
제 2 항에 있어서,
상기 염기는 탄산칼륨, 탄산나트륨, 탄산수소칼륨, 탄산수소나트륨, 수산화나트륨 및 수산화칼륨으로 이루어진 군으로부터 선택된 무기 염기인, 제조 방법.
The method of claim 2,
The base is an inorganic base selected from the group consisting of potassium carbonate, sodium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, sodium hydroxide and potassium hydroxide.
제 2 항에 있어서,
상기 염기는 트리에틸아민, 다이아이소프로필에틸아민, 다이에틸아민 및 피리딘으로 이루어진 군으로부터 선택된 유기 염기인, 제조 방법.
The method of claim 2,
The base is an organic base selected from the group consisting of triethylamine, diisopropylethylamine, diethylamine, and pyridine.
삭제delete 삭제delete 삭제delete 삭제delete
KR1020190161828A 2019-10-11 2019-12-06 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate KR102179649B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
PCT/KR2020/002959 WO2021071033A1 (en) 2019-10-11 2020-03-02 Method for preparing diethylamino hydroxybenzoyl hexyl benzoate
JP2020573548A JP7195351B2 (en) 2019-10-11 2020-03-02 Method for producing hexyl diethylaminohydroxybenzoylbenzoate
CN202080042581.9A CN113993838A (en) 2019-10-11 2020-03-02 Method for producing diethylamino hydroxybenzoyl hexyl benzoate
DE112020004927.2T DE112020004927T5 (en) 2019-10-11 2020-03-02 Production process for diethylaminohydroxybenzoylhexyl benzoate
KR1020200057898A KR102357197B1 (en) 2019-10-11 2020-05-14 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
TW109142958A TW202122369A (en) 2019-10-11 2020-12-04 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
JP2022154975A JP2022188148A (en) 2019-10-11 2022-09-28 Method for preparing diethylamino hydroxybenzoyl hexyl benzoate
JP2022154976A JP2022188149A (en) 2019-10-11 2022-09-28 Method of producing hexyl diethylamino hydroxybenzoyl benzoate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190126502 2019-10-11
KR20190126502 2019-10-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020200057898A Division KR102357197B1 (en) 2019-10-11 2020-05-14 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate

Publications (2)

Publication Number Publication Date
KR20200002720A KR20200002720A (en) 2020-01-08
KR102179649B1 true KR102179649B1 (en) 2020-11-18

Family

ID=69154356

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020190161828A KR102179649B1 (en) 2019-10-11 2019-12-06 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
KR1020200057898A KR102357197B1 (en) 2019-10-11 2020-05-14 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
KR1020210156960A KR102439837B1 (en) 2019-10-11 2021-11-15 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020200057898A KR102357197B1 (en) 2019-10-11 2020-05-14 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
KR1020210156960A KR102439837B1 (en) 2019-10-11 2021-11-15 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate

Country Status (6)

Country Link
JP (3) JP7195351B2 (en)
KR (3) KR102179649B1 (en)
CN (1) CN113993838A (en)
DE (1) DE112020004927T5 (en)
TW (1) TW202122369A (en)
WO (1) WO2021071033A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102179649B1 (en) * 2019-10-11 2020-11-18 (주)에이에스텍 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
KR20220147622A (en) * 2020-02-27 2022-11-03 바스프 에스이 Method for isolating 2-(4'-diethylamino-2'-hydroxybenzoyl)benzoic acid hexyl ester
CN112479890B (en) * 2020-11-27 2023-09-26 苏州亚科科技股份有限公司 Preparation method of nitro compound
EP4263490A1 (en) * 2020-12-18 2023-10-25 Basf Se Method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate
CN112679393A (en) * 2020-12-31 2021-04-20 江苏科本药业有限公司 Preparation method of sofosbuvir impurity
CN114149339B (en) * 2021-12-28 2023-01-31 黄冈美丰化工科技有限公司 Ultraviolet absorbent, composition, cosmetic and process for preparing cosmetic
CN115010615B (en) * 2022-07-14 2023-12-08 四川沃肯精细化工有限公司 Preparation method of diethylamino hydroxybenzoyl n-hexyl benzoate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533764A (en) * 2002-05-15 2005-11-10 ビーエーエスエフ アクチェンゲゼルシャフト Process for producing 2- (4-N, N-dialkylamino-2-hydroxybenzoyl) benzoate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935543A (en) * 1988-05-20 1990-06-19 Takeda Chemical Industries, Ltd. Physiologically active substance tan-931, its derivatives, their production and use
JPH0733709A (en) * 1993-07-27 1995-02-03 Tanabe Seiyaku Co Ltd Production of oxalic acid monoester compound
KR100236388B1 (en) * 1995-11-28 1999-12-15 성재갑 Novel uv-light screening polymers and their preparation method
DE19917906A1 (en) 1999-04-20 2000-10-26 Basf Ag Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations
DE10011317A1 (en) 2000-03-10 2001-09-13 Basf Ag Use of amino-substituted hydroxybenzophenones as photoprotective agents and stabilizers for nonliving organic materials, especially plastics, polymer dispersions, lacquers and photographic emulsions
DE10342861A1 (en) 2003-09-15 2005-04-21 Basf Ag Powdered preparations containing a mixture of 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxi) -1,3,5-triazine and diethylamino-hydroxybenzoyl-hexyl-benzoate
ES2402170T3 (en) 2007-05-02 2013-04-29 Basf Se Process for crystallization of N-hexyl 2- (4-N, N-diethylamino-2-hydroxybenzoyl) -benzoate
EP2288424A2 (en) * 2008-05-21 2011-03-02 The Regents of the University of Colorado Ionic liquids and methods for using the same
JP4299878B1 (en) 2008-10-06 2009-07-22 株式会社パラエルモサ Cosmetics
US8652448B2 (en) 2009-12-24 2014-02-18 Kao Corporation Hydrogel particles
JP2014210715A (en) 2013-04-17 2014-11-13 ロート製薬株式会社 Aminohydroxybenzophenone derivative, method for producing the same and ultraviolet absorber and skin external preparation using the same
PL3371147T3 (en) * 2015-11-04 2021-10-25 Otsuka Pharmaceutical Co., Ltd. Innovative preparation and crystallization of iosimenol
KR102179649B1 (en) * 2019-10-11 2020-11-18 (주)에이에스텍 A preparing method of diethylamino hydroxybenzoyl hexylbenzoate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533764A (en) * 2002-05-15 2005-11-10 ビーエーエスエフ アクチェンゲゼルシャフト Process for producing 2- (4-N, N-dialkylamino-2-hydroxybenzoyl) benzoate

Also Published As

Publication number Publication date
KR102439837B1 (en) 2022-09-05
CN113993838A (en) 2022-01-28
TW202122369A (en) 2021-06-16
KR20210071804A (en) 2021-06-16
KR20210142575A (en) 2021-11-25
JP2022188148A (en) 2022-12-20
JP2021533088A (en) 2021-12-02
KR102357197B1 (en) 2022-02-03
DE112020004927T5 (en) 2022-06-23
JP7195351B2 (en) 2022-12-23
WO2021071033A9 (en) 2021-10-14
KR20200002720A (en) 2020-01-08
JP2022188149A (en) 2022-12-20
WO2021071033A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
KR102179649B1 (en) A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
EP1025107A1 (en) Photochromic compounds
JP2008266172A (en) Method for producing 3-o-alkyl-5,6-o-(1-methylethylidene)-l-ascorbic acid and method for producing 5,6-o-(1-methylethylidene)-l-ascorbic acid
KR100551926B1 (en) Process for producing cilostazol
KR100674522B1 (en) Process for Preparation of Spirofluorenols
US4062854A (en) Process for preparing N-substituted-8,13-dioxodinaphtho-(2,1-b; 2',3'-di-fluran-6-carboxamides
RU2315042C2 (en) Photochrome oxazine compounds and method for their producing
JPS62149679A (en) Hydroxyphenylpropionic acid ester having novel crystal structure and production thereof
EP0206789B1 (en) Crystalline hydroxyphenylpropionic acid ester and its production
KR102633630B1 (en) A preparation method for n-hexyl-2-(4-n,n-diethylamino-2-hydroxybenzoylbenzoate
DE4329727C2 (en) Process for the preparation of hydroxyalkylaminonitrobenzene derivatives
KR102109210B1 (en) Phosphorus-based (meth)acrylate compound and method for preparation thereof
CA1059518A (en) Process for preparing 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl) pyridine
TW201808904A (en) Process for preparing boscalid
CH640226A5 (en) TWO-STAGE PROCEDURE TO PREPARE A MOL-TO-MOL ADDITION COMPOUND BETWEEN 2-6-PYRIDIN-BICARBOSSYLIC ACID AND CHROMIC DIOXIDE.
JPS6395269A (en) Naphthalocyanine compound
JPS62255454A (en) Production of 2-(4,4'-bis(dimethylamino)-benzohydryl)-5-dimethylaminobenz-oic acid
JPS58152855A (en) Preparation of lower alkoxybenzonitrile
JPS6032756A (en) Production of n-(cis-3,4-dimethoxycinnamoyl)-anthranylic acid
JPH09286766A (en) Production of higher alcohol ester of amino-chlorobnenzoic acid
JPH04208252A (en) Purification of bis(2,3-dihydroxypropyl)amine
JPH0368571A (en) Production of n-substituted 2,4,6-triiminotriazine derivative
JPH06287176A (en) Production of 2-amino-3-nitropyridine
JP2002220390A (en) Anhydrous mirtazapine and its manufacturing method
JPH04260607A (en) Production of trithiocarbonate

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant